(Reuters) -Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in ...

A panel for the Centers for Disease Control and Prevention voted to lower the recommended age for older adults to get their ...

In October, the CDC lowered the age recommendation for the vaccine against pneumonia. Before, it was 65 and older. The health ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

The vaccine protects against serious infections including invasive diseases that attack parts of the body that are normally ...

It started with a cough that wouldn’t go away. Before she knew it, Karyne Jones was hospitalized with pneumonia in January 2018. Even after the bacteria cleared her body, it took her three ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

The Centers for Disease Control and Prevention (CDC) has lowered the recommended age for the pneumonia vaccine from 65 to 50 for adults. “Lowering the age for pneumococcal vaccination gives more ...

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.